Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323

Status:
Terminated

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

The objective of the study is to evaluate the effect, safety and tolerability of CDP323 in patients with relapsing forms of multiple sclerosis

Phase 2

UCB Pharma

Biogen